Clinical Trials
8 trialsNCT03547388 2020-05-05
GKH-TMM
Charite University, Berlin, Germany
Phase 1 Completed
NCT01924689 2019-09-09
Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies
BioMed Valley Discoveries, Inc
Phase 1 Completed
NCT02128724 2019-08-01
BKM120
University of Oxford
Phase 1 Completed
NCT03098160 2017-10-30
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Threshold Pharmaceuticals
Phase 1 Unknown
NCT00358397 2016-10-14
One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Terminated
NCT01118819 2016-01-20
Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies
BioMed Valley Discoveries, Inc
Phase 1 Terminated
NCT00495144 2012-07-27
A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors
Threshold Pharmaceuticals
Phase 1 Completed
NCT00090727 2006-11-02
Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Novacea
Phase 1 Unknown